Pacer Advisors Portfolio holdings
AUM
$39.6B
1-Year Return
5.04%
This Quarter Return
-4.31%
1 Year Return
+5.04%
3 Year Return
+42.86%
5 Year Return
+91.64%
10 Year Return
+332.32%
AUM
$43.7B
AUM Growth
+$158M
(+0.36%)
Cap. Flow
+$1.17B
Cap. Flow
% of AUM
2.67%
Top 10 Holdings %
Top 10 Hldgs %
11.64%
Holding
4,109
New
199
Increased
895
Reduced
1,260
Closed
190
Top Buys
| 1 |
Hewlett Packard
HPE
|
$488M |
| 2 |
Halliburton
HAL
|
$458M |
| 3 |
Archer Daniels Midland
ADM
|
$456M |
| 4 |
Gen Digital
GEN
|
$413M |
| 5 |
WESCO International
WCC
|
$251M |
Top Sells
| 1 |
Vistra
VST
|
$614M |
| 2 |
Exxon Mobil
XOM
|
$498M |
| 3 |
Chevron
CVX
|
$435M |
| 4 |
Occidental Petroleum
OXY
|
$432M |
| 5 |
Cisco
CSCO
|
$411M |
Sector Composition
| 1 | Consumer Discretionary | 17.28% |
| 2 | Technology | 17.14% |
| 3 | Energy | 14.05% |
| 4 | Industrials | 10.98% |
| 5 | Healthcare | 9.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1376
Altimmune
ALT
$314M
| $8.38K | ﹤0.01% |
1,260
-2,899
| -70% | -$19.3K |
|
1377
Arcus Biosciences
RCUS
$1.23B
| $8.3K | ﹤0.01% |
545
-1,034
| -65% | -$15.7K |
|
1378
Immunome
IMNM
$853M
| $7.99K | ﹤0.01% |
+660
| New | +$7.99K |
|
1379
CareDx
CDNA
$697M
| $7.91K | ﹤0.01% |
509
-1,189
| -70% | -$18.5K |
|
|
SAGE
1380
DELISTED
Sage Therapeutics
SAGE
| $7.61K | ﹤0.01% |
701
-1,125
| -62% | -$12.2K |
|
|
CDMO
1381
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $7.48K | ﹤0.01% |
1,048
-1,402
| -57% | -$10K |
|
1382
Summit Therapeutics
SMMT
$17.7B
| $7.36K | ﹤0.01% |
944
-2,085
| -69% | -$16.3K |
|
1383
Organon & Co
OGN
$2.52B
| $7.25K | ﹤0.01% |
350
+48
| +16% | +$994 |
|
1384
Relay Therapeutics
RLAY
$690M
| $7.19K | ﹤0.01% |
1,103
-1,054
| -49% | -$6.87K |
|
1385
AnaptysBio
ANAB
$590M
| $7.09K | ﹤0.01% |
283
-139
| -33% | -$3.48K |
|
1386
Ocugen
OCGN
$322M
| $7.03K | ﹤0.01% |
+4,534
| New | +$7.03K |
|
1387
Skillz
SKLZ
$111M
| $6.99K | ﹤0.01% |
974
-141
| -13% | -$1.01K |
|
1388
Regenxbio
RGNX
$476M
| $6.87K | ﹤0.01% |
587
-248
| -30% | -$2.9K |
|
1389
Teladoc Health
TDOC
$1.35B
| $6.81K | ﹤0.01% |
696
-1,544
| -69% | -$15.1K |
|
1390
89bio
ETNB
$1.28B
| $6.54K | ﹤0.01% |
816
-1,330
| -62% | -$10.7K |
|
1391
Kiniksa Pharmaceuticals
KNSA
$2.63B
| $6.44K | ﹤0.01% |
345
-315
| -48% | -$5.88K |
|
1392
Scholar Rock
SRRK
$3.12B
| $6.3K | ﹤0.01% |
756
-856
| -53% | -$7.13K |
|
1393
Olema Pharmaceuticals
OLMA
$436M
| $6.28K | ﹤0.01% |
580
-789
| -58% | -$8.54K |
|
1394
Stoke Therapeutics
STOK
$1.08B
| $6.13K | ﹤0.01% |
+454
| New | +$6.13K |
|
1395
Disc Medicine
IRON
$2.09B
| $6.13K | ﹤0.01% |
136
-341
| -71% | -$15.4K |
|
1396
Corbus Pharmaceuticals
CRBP
$123M
| $5.97K | ﹤0.01% |
+132
| New | +$5.97K |
|
1397
Editas Medicine
EDIT
$227M
| $5.71K | ﹤0.01% |
1,222
-2,526
| -67% | -$11.8K |
|
1398
Astria Therapeutics
ATXS
$395M
| $5.58K | ﹤0.01% |
613
-119
| -16% | -$1.08K |
|
1399
Allogene Therapeutics
ALLO
$246M
| $5.53K | ﹤0.01% |
2,372
-1,285
| -35% | -$2.99K |
|
1400
MiMedx Group
MDXG
$1.05B
| $5.45K | ﹤0.01% |
786
-558
| -42% | -$3.87K |
|